Literature DB >> 23873821

Impaired quality of life, disability and mental health in Takayasu's arteritis.

Neslihan Yilmaz1, Meryem Can, Fatma Alibaz Oner, Melike Kalfa, Hakan Emmungil, Omer Karadag, Fatih Yildiz, Gezmis Kimyon, Baris Yilmazer, Vedat Gerdan, Sule Yasar Bilge, Birkan Ilhan, Veli Cobankara, Timucin Kasifoglu, Ayse Cefle, Bunyamin Kisacik, Ahmet Mesut Onat, Servet Akar, Fatos Onen, Eren Erken, Sedat Kiraz, Kenan Aksu, Gokhan Keser, Gonca Mumcu, Haner Direskeneli.   

Abstract

OBJECTIVE: Patient-reported outcomes (PROs) are increasingly accepted to be among the major tools for outcome assessment in rheumatic disorders. In this study we aimed to assess quality of life (QoL), disability, anxiety and depression in patients with Takayasu's arteritis (TAK).
METHODS: Patients followed with the diagnosis of TAK (n = 165) and healthy controls (HCs) (n = 109) were enrolled to the study. The 36-item Short Form Health Survey (SF-36) and hospital anxiety and depression scales (HADS) were used to assess QoL and mental status together with HAQ for disability.
RESULTS: In SF-36 subscale assessment, all items were observed to be statistically lower in TAK patients; similarly HAQ scores were also higher (P < 0.001) in this group. In mental assessment, anxiety was found to be more common in TAK patients [90 (54.5%) vs 38 (34.9%), P = 0.001]. Depression also tended to be higher in TAK patients [70 (66.7%) vs 35 (33.3%)], without reaching significance (P = 0.086). Most of the SF-36 subgroup parameters were lower in TAK patients with active disease. Patients having anxiety and depression or with high HAQ scores reported worse SF-36 scores. In multivariate analysis, HADS-A, HADS-D and HAQ were associated with most SF-36 subscales.
CONCLUSION: PROs demonstrate that not only general health but also physical and social functioning with physical role limitations and mental health parameters were impaired in TAK. Our results, especially in active disease, suggest that PROs such as SF-36 can be core domains of disease assessment in TAK, similar to ANCA-associated vasculitides.

Entities:  

Keywords:  Takayasu’s arteritis; function; mental status; quality of life

Mesh:

Year:  2013        PMID: 23873821     DOI: 10.1093/rheumatology/ket238

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  16 in total

Review 1.  Productivity Losses and Costs in the Less-Common Systemic Autoimmune Rheumatic Diseases.

Authors:  Natalie McCormick; Carlo A Marra; J Antonio Aviña-Zubieta
Journal:  Curr Rheumatol Rep       Date:  2017-10-30       Impact factor: 4.592

Review 2.  Recent advances in Takayasu's arteritis.

Authors:  Fatma Alibaz-Öner; Sibel Zehra Aydın; Haner Direskeneli
Journal:  Eur J Rheumatol       Date:  2015-03-01

3.  Cyclophosphamide could be a better choice than methotrexate as induction treatment for patients with more severe Takayasu's arteritis.

Authors:  Ying Sun; Lili Ma; Lingying Ma; Xiufang Kong; Huiyong Chen; Peng Lv; Jiang Lin; Hao Liu; Yan Yan; Zongfei Ji; Chengde Yang; Shengming Dai; Weiguo Wan; Yaohong Zou; Xuejuan Jin; Lindi Jiang
Journal:  Rheumatol Int       Date:  2017-10-13       Impact factor: 2.631

4.  Analysis of predictive factors for treatment resistance and disease relapse in Takayasu's arteritis.

Authors:  Ying Sun; Lili Ma; Huiyong Chen; Xiufang Kong; Peng Lv; Xiaomin Dai; Zongfei Ji; Chengde Yang; Shengming Dai; Lijun Wu; Yaohong Zou; Jiang Lin; Hongcheng Shi; Qiang Yu; Lindi Jiang
Journal:  Clin Rheumatol       Date:  2018-04-23       Impact factor: 2.980

Review 5.  Update on Outcome Measure Development for Large Vessel Vasculitis: Report from OMERACT 12.

Authors:  Sibel Zehra Aydin; Haner Direskeneli; Antoine Sreih; Fatma Alibaz-Oner; Ahmet Gul; Sevil Kamali; Gulen Hatemi; Tanaz Kermani; Sarah L Mackie; Alfred Mahr; Alexa Meara; Nataliya Milman; Heidi Nugent; Joanna Robson; Gunnar Tomasson; Peter A Merkel
Journal:  J Rheumatol       Date:  2015-06-15       Impact factor: 4.666

6.  Update on Outcome Measure Development in Large-vessel Vasculitis: Report from OMERACT 2018.

Authors:  Sibel Z Aydin; Joanna C Robson; Antoine G Sreih; Catherine Hill; Fatma Alibaz-Oner; Sarah Mackie; Susan Beard; Ahmet Gul; Gülen Hatemi; Tanaz A Kermani; Alfred Mahr; Alexa Meara; Nataliya Milman; Beverley Shea; Gunnar Tómasson; Peter Tugwell; Haner Direskeneli; Peter A Merkel
Journal:  J Rheumatol       Date:  2019-03-15       Impact factor: 4.666

7.  Development of a Core Set of Outcome Measures for Large-vessel Vasculitis: Report from OMERACT 2016.

Authors:  Antoine G Sreih; Fatma Alibaz-Oner; Tanaz A Kermani; Sibel Z Aydin; Peter F Cronholm; Trocon Davis; Ebony Easley; Ahmet Gul; Alfred Mahr; Carol A McAlear; Nataliya Milman; Joanna C Robson; Gunnar Tomasson; Haner Direskeneli; Peter A Merkel
Journal:  J Rheumatol       Date:  2017-09-01       Impact factor: 4.666

Review 8.  Physical Exercise in Managing Takayasu Arteritis Patients Complicated With Cardiovascular Diseases.

Authors:  Yaxin Zhou; Yuan Feng; Wei Zhang; Hongxia Li; Kui Zhang; Zhenbiao Wu
Journal:  Front Cardiovasc Med       Date:  2021-05-12

9.  Clinical characteristics, imaging phenotypes and events free survival in Takayasu arteritis patients with hypertension.

Authors:  Sun Ying; Wu Sifan; Wang Yujiao; Chen Rongyi; Huang Qingrong; Ma Lili; Chen Huiyong; Jiang Lindi
Journal:  Arthritis Res Ther       Date:  2021-07-21       Impact factor: 5.156

10.  Vasculitis syndromes: Vasculitis assessments--what do patients think?

Authors:  Paul A Bacon; Tessa Sanderson
Journal:  Nat Rev Rheumatol       Date:  2013-10-08       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.